Philadelphia Biotech Startup Context Therapeutics Names a New CFO, Effective Immediately Post author:Sam Post published:November 15, 2017 Post category:BioPharma The company is strengthening its team as it transitions to a clinical development stage company. Source: BioSpace You Might Also Like Akebia Announces $85M Public Offering March 22, 2018 Analgesic Solutions Presents Data On The Use Of MADDERS To Assess Potentially Abuse-Related Events In Clinical Trials At The June 18, 2017 China-Focused Life Science Investor Acquires 37% of NovaBay for $28M December 27, 2017
Analgesic Solutions Presents Data On The Use Of MADDERS To Assess Potentially Abuse-Related Events In Clinical Trials At The June 18, 2017